Analgesics
Antiandrogens
Antihistamines
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Monoclonals
Mpro inhibitors
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Quercetin
RdRp inhibitors
Thermotherapy
Vitamins
More

Other
Feedback
Home
 
next
study
previous
study
c19early.org COVID-19 treatment researchIota-carrageenanIota-carragee.. (more..)
Metformin Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta
Ivermectin Meta Thermotherapy Meta
Melatonin Meta

All Studies   Meta Analysis       

Over-the-counter carrageenan-based sprays may interfere with PCR testing of nasopharyngeal swabs to detect SARS-CoV-2

Corocher et al., PLOS ONE, doi:10.1371/journal.pone.0316700
Feb 2025  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
In Vitro study showing that carrageenan may interfere with PCR testing for SARS-CoV-2 on nasopharyngeal swabs, potentially leading to false negative results. Seegene STARlet was most affected, frequently returning invalid results, while qualitative accuracy was maintained on GeneXpert, LIAT, and Panther, although Ct values still increased on some. A preliminary in vivo analysis showed interference peaked at 15 minutes and largely resolved by 30 minutes after administration of a carrageenan nasal spray. The study’s reliance on spiked samples, which may not reflect real-world concentrations, and a single-subject for in vivo tests limits conclusions.
15 preclinical studies support the efficacy of iota-carrageenan for COVID-19:
Corocher et al., 6 Feb 2025, peer-reviewed, 7 authors. Contact: taylor.corocher@nh.org.au.
This PaperIota-carragee..All
Over-the-counter carrageenan-based sprays may interfere with PCR testing of nasopharyngeal swabs to detect SARS-CoV-2
Taylor Corocher, Kira Edwards, Yvonne Hersusianto, Donald Campbell, Hui Yin Lim, Paul Monagle, Prahlad Ho
PLOS ONE, doi:10.1371/journal.pone.0316700
Carrageenan-containing nasal sprays, available over-the-counter (OTC), are often marketed as having anti-viral effects. Carrageenan belongs to the glycosaminoglycan family alongside heparin, and heparin is known to inhibit real-time quantitative polymerase chain reaction (RT-qPCR) in nasopharyngeal swabs used to detect SARS-CoV-2. As heparin and carrageenan share structural similarities, this work aimed to investigate the interferent effect of carrageenan on RT-qPCR for SARS-CoV-2 detection across 4 different diagnostic platforms. This work demonstrated that in the presence of carrageenan samples return inaccurate and invalid results on the Seegene STARlet, while qualitative accuracy was maintained on the Cepheid GeneXpert, Roche Cobas LIAT, and Hologic Panther Aptima. Evidence of carrageenan interference on SARS-CoV-2 testing was consistent across two OTC brands and research-grade reconstituted iota-carrageenan, with 80% of results returning invalid regardless of the carrageenan formulation added to the samples. Further, a preliminary in vivo interference study demonstrated an increased Ct value within 15 minutes of carrageenan dosage, with Ct values restored 60 minutes post-application. A direct comparison of carrageenan-and heparin-mediated PCR interference demonstrated that carrageenan PCR interference occurs to a lesser degree, but is not reversible by the addition of heparinase I. As carrageenan is available OTC, interference with PCR testing that causes an increase in false negative results could lead to accidental spread of disease and could therefore have significant public health impacts on community testing of respiratory infectious diseases via PCR.
Supporting information S1 Table. 95% Confidence intervals (CI) for the CT values of the E-gene from samples presented in Formal analysis: Taylor Corocher, Kira Edwards. Funding acquisition: Donald Campbell, Paul Monagle. Investigation: Taylor Corocher, Kira Edwards. Methodology: Taylor Corocher, Kira Edwards. Project administration: Kira Edwards. Resources: Hui Yin Lim. Supervision: Yvonne Hersusianto, Donald Campbell, Hui Yin Lim, Paul Monagle, Prahlad Ho. Validation: Taylor Corocher. Visualization: Taylor Corocher, Kira Edwards. Writing -original draft: Taylor Corocher, Kira Edwards. Writing -review & editing: Taylor Corocher, Kira Edwards, Yvonne Hersusianto, Donald Campbell, Paul Monagle, Prahlad Ho.
References
Bovard, Van Der Toorn, Schlage, Constant, Renggli et al., Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia, Biochem Biophys Rep, doi:10.1016/j.bbrep.2021.101187
Eccles, Meier, Jawad, Weinmüllner, Grassauer et al., Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold, Respir Res, doi:10.1186/1465-9921-11-108
Eccles, Winther, Johnston, Robinson, Trampisch et al., Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial, doi:10.1186/s12931-015-0281-8
Edwards, Corocher, Hersusianto, Campbell, Subbarao et al., Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I, J Virol Methods, doi:10.1016/j.jviromet.2024.114944
Fazekas, Eickhoff, Pruckner, Vollnhofer, Fischmeister et al., Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold, BMC Complement Altern Med, doi:10.1186/1472-6882-12-147
Fröba, Große, Setz, Rauch, Auth et al., Iota-carrageenan inhibits replication of SARS-CoV-2 and the respective variants of concern Alpha, Beta, Gamma and Delta, Int J Mol Sci, doi:10.3390/ijms222413202
Hugerth, Sundelöf, Effect of polyelectrolyte counterion specificity on dextran sulfate-amphiphile interaction in water and aqueous/organic solvent mixtures, Langmuir, doi:10.1021/la9916880
Laurie, El-Zein, Franco, Coutlée, Assessment of the possible inhibitory effect of carrageenan in human papillomavirus DNA testing by polymerase chain reaction amplification, J Med Virol, doi:10.1002/jmv.26963
Laurienzo, Marine polysaccharides in pharmaceutical applications: an overview, Mar Drugs, doi:10.3390/md8092435
Ludwig, Enzenhofer, Schneider, Rauch, Bodenteich et al., Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial, Respir Res, doi:10.1186/1465-9921-14-124
Mahomoodally, Lobine, Rengasamy, Gowrishankar, Tewari et al., Marine algae: a potential resource of Anti-HSV molecules, doi:10.3390/pr7120887
Necas, Bartosikova, Carrageenan: a review, Vet Med, doi:10.17221/6758-vetmed
Pangestuti, Kim, Biological activities of carrageenan, Adv Food Nutr Res, doi:10.1016/B978-0-12-800269-8.00007-5
Shi, Wang, Lu, Qin, Hu et al., Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds, Carbohydrate Res, doi:10.1016/j.carres.2017.10.020
Weiss, Esko, Tor, Biomol, Author, Targeting heparin and heparan sulfate protein interactions, Org Biomol Chem, doi:10.1039/c7ob01058c
DOI record: { "DOI": "10.1371/journal.pone.0316700", "ISSN": [ "1932-6203" ], "URL": "http://dx.doi.org/10.1371/journal.pone.0316700", "abstract": "<jats:p>Carrageenan-containing nasal sprays, available over-the-counter (OTC), are often marketed as having anti-viral effects. Carrageenan belongs to the glycosaminoglycan family alongside heparin, and heparin is known to inhibit real-time quantitative polymerase chain reaction (RT-qPCR) in nasopharyngeal swabs used to detect SARS-CoV-2. As heparin and carrageenan share structural similarities, this work aimed to investigate the interferent effect of carrageenan on RT-qPCR for SARS-CoV-2 detection across 4 different diagnostic platforms. This work demonstrated that in the presence of carrageenan samples return inaccurate and invalid results on the Seegene STARlet, while qualitative accuracy was maintained on the Cepheid GeneXpert, Roche Cobas LIAT, and Hologic Panther Aptima. Evidence of carrageenan interference on SARS-CoV-2 testing was consistent across two OTC brands and research-grade reconstituted iota-carrageenan, with 80% of results returning invalid regardless of the carrageenan formulation added to the samples. Further, a preliminary <jats:italic>in vivo</jats:italic> interference study demonstrated an increased Ct value within 15 minutes of carrageenan dosage, with Ct values restored 60 minutes post-application. A direct comparison of carrageenan- and heparin-mediated PCR interference demonstrated that carrageenan PCR interference occurs to a lesser degree, but is not reversible by the addition of heparinase I. As carrageenan is available OTC, interference with PCR testing that causes an increase in false negative results could lead to accidental spread of disease and could therefore have significant public health impacts on community testing of respiratory infectious diseases via PCR.</jats:p>", "author": [ { "ORCID": "https://orcid.org/0000-0003-1127-0500", "affiliation": [], "authenticated-orcid": true, "family": "Corocher", "given": "Taylor", "sequence": "first" }, { "ORCID": "https://orcid.org/0000-0002-8169-5187", "affiliation": [], "authenticated-orcid": true, "family": "Edwards", "given": "Kira", "sequence": "additional" }, { "affiliation": [], "family": "Hersusianto", "given": "Yvonne", "sequence": "additional" }, { "affiliation": [], "family": "Campbell", "given": "Donald", "sequence": "additional" }, { "ORCID": "https://orcid.org/0000-0003-2455-3155", "affiliation": [], "authenticated-orcid": true, "family": "Lim", "given": "Hui Yin", "sequence": "additional" }, { "affiliation": [], "family": "Monagle", "given": "Paul", "sequence": "additional" }, { "affiliation": [], "family": "Ho", "given": "Prahlad", "sequence": "additional" } ], "container-title": "PLOS ONE", "container-title-short": "PLoS ONE", "content-domain": { "crossmark-restriction": false, "domain": [ "www.plosone.org" ] }, "created": { "date-parts": [ [ 2025, 2, 6 ] ], "date-time": "2025-02-06T18:59:02Z", "timestamp": 1738868342000 }, "deposited": { "date-parts": [ [ 2025, 2, 6 ] ], "date-time": "2025-02-06T18:59:16Z", "timestamp": 1738868356000 }, "editor": [ { "affiliation": [], "family": "Lin", "given": "Shih-Chao", "sequence": "first" } ], "funder": [ { "name": "Victorian Government Department of Jobs, Skills, Industry and Regions" }, { "name": "Victorian Government Department of Jobs, Skills, Industry and Regions" } ], "indexed": { "date-parts": [ [ 2025, 2, 6 ] ], "date-time": "2025-02-06T19:40:06Z", "timestamp": 1738870806610, "version": "3.37.0" }, "is-referenced-by-count": 0, "issue": "2", "issued": { "date-parts": [ [ 2025, 2, 6 ] ] }, "journal-issue": { "issue": "2", "published-online": { "date-parts": [ [ 2025, 2, 6 ] ] } }, "language": "en", "license": [ { "URL": "http://creativecommons.org/licenses/by/4.0/", "content-version": "vor", "delay-in-days": 0, "start": { "date-parts": [ [ 2025, 2, 6 ] ], "date-time": "2025-02-06T00:00:00Z", "timestamp": 1738800000000 } } ], "link": [ { "URL": "https://dx.plos.org/10.1371/journal.pone.0316700", "content-type": "unspecified", "content-version": "vor", "intended-application": "similarity-checking" } ], "member": "340", "original-title": [], "page": "e0316700", "prefix": "10.1371", "published": { "date-parts": [ [ 2025, 2, 6 ] ] }, "published-online": { "date-parts": [ [ 2025, 2, 6 ] ] }, "publisher": "Public Library of Science (PLoS)", "reference": [ { "DOI": "10.1016/j.jviromet.2024.114944", "article-title": "Heparin-mediated PCR interference in SARS-CoV-2 assays and subsequent reversal with heparinase I", "author": "K Edwards", "doi-asserted-by": "crossref", "first-page": "114944", "journal-title": "J Virol Methods", "key": "pone.0316700.ref001", "volume": "327", "year": "2024" }, { "DOI": "10.17221/6758-VETMED", "article-title": "Carrageenan: a review", "author": "J Necas", "doi-asserted-by": "crossref", "first-page": "187", "issue": "4", "journal-title": "Vet Med", "key": "pone.0316700.ref002", "volume": "58", "year": "2013" }, { "key": "pone.0316700.ref003", "unstructured": "Carrageenan market size and share analysis report; 2030. [cited 2024 Feb 1]. Available from: https://www.grandviewresearch.com/industry-analysis/carrageenan-market" }, { "DOI": "10.1002/jmv.26963", "article-title": "Assessment of the possible inhibitory effect of carrageenan in human papillomavirus DNA testing by polymerase chain reaction amplification", "author": "C Laurie", "doi-asserted-by": "crossref", "first-page": "6408", "issue": "11", "journal-title": "J Med Virol", "key": "pone.0316700.ref004", "volume": "93", "year": "2021" }, { "DOI": "10.3390/pr7120887", "article-title": "Marine algae: a potential resource of Anti-HSV molecules", "author": "MF Mahomoodally", "doi-asserted-by": "crossref", "first-page": "887", "issue": "12", "journal-title": "Processes", "key": "pone.0316700.ref005", "volume": "7", "year": "2019" }, { "DOI": "10.1016/B978-0-12-800269-8.00007-5", "article-title": "Biological activities of carrageenan", "author": "R Pangestuti", "doi-asserted-by": "crossref", "first-page": "113", "journal-title": "Adv Food Nutr Res", "key": "pone.0316700.ref006", "volume": "72", "year": "2014" }, { "DOI": "10.1016/j.carres.2017.10.020", "article-title": "Overview on the antiviral activities and mechanisms of marine polysaccharides from seaweeds", "author": "Q Shi", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "Carbohydrate Res", "key": "pone.0316700.ref007", "year": "2017" }, { "DOI": "10.3390/md8092435", "article-title": "Marine polysaccharides in pharmaceutical applications: an overview", "author": "P Laurienzo", "doi-asserted-by": "crossref", "first-page": "2435", "issue": "9", "journal-title": "Mar Drugs", "key": "pone.0316700.ref008", "volume": "8", "year": "2010" }, { "DOI": "10.1186/1465-9921-11-108", "article-title": "Efficacy and safety of an antiviral Iota-Carrageenan nasal spray: a randomized, double-blind, placebo-controlled exploratory study in volunteers with early symptoms of the common cold", "author": "R Eccles", "doi-asserted-by": "crossref", "first-page": "108", "issue": "1", "journal-title": "Respir Res", "key": "pone.0316700.ref009", "volume": "11", "year": "2010" }, { "article-title": "Efficacy and safety of iota-carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial", "author": "R Eccles", "key": "pone.0316700.ref010", "year": "2012" }, { "DOI": "10.1186/1472-6882-12-147", "article-title": "Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold", "author": "T Fazekas", "doi-asserted-by": "crossref", "first-page": "1", "journal-title": "BMC Complement Altern Med", "key": "pone.0316700.ref011", "volume": "12", "year": "2012" }, { "DOI": "10.1186/1465-9921-14-124", "article-title": "Efficacy of a carrageenan nasal spray in patients with common cold: a randomized controlled trial", "author": "M Ludwig", "doi-asserted-by": "crossref", "first-page": "1", "issue": "1", "journal-title": "Respir Res", "key": "pone.0316700.ref012", "volume": "14", "year": "2013" }, { "article-title": "Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia", "author": "D Bovard", "first-page": "101187", "journal-title": "Biochem Biophys Rep", "key": "pone.0316700.ref013", "volume": "29", "year": "2022" }, { "DOI": "10.3390/ijms222413202", "article-title": "Iota-carrageenan inhibits replication of SARS-CoV-2 and the respective variants of concern Alpha, Beta, Gamma and Delta", "author": "M Fröba", "doi-asserted-by": "crossref", "first-page": "13202", "issue": "24", "journal-title": "Int J Mol Sci", "key": "pone.0316700.ref014", "volume": "22", "year": "2021" }, { "DOI": "10.1039/C7OB01058C", "article-title": "Targeting heparin and heparan sulfate protein interactions", "author": "RJ Weiss", "doi-asserted-by": "crossref", "first-page": "5656", "issue": "27", "journal-title": "Org Biomol Chem", "key": "pone.0316700.ref015", "volume": "15", "year": "2017" }, { "DOI": "10.1021/la9916880", "article-title": "Effect of polyelectrolyte counterion specificity on dextran sulfate−amphiphile interaction in water and aqueous/organic solvent mixtures", "author": "A Hugerth", "doi-asserted-by": "crossref", "first-page": "4940", "issue": "11", "journal-title": "Langmuir", "key": "pone.0316700.ref016", "volume": "16", "year": "2000" } ], "reference-count": 16, "references-count": 16, "relation": {}, "resource": { "primary": { "URL": "https://dx.plos.org/10.1371/journal.pone.0316700" } }, "score": 1, "short-title": [], "source": "Crossref", "subject": [], "subtitle": [], "title": "Over-the-counter carrageenan-based sprays may interfere with PCR testing of nasopharyngeal swabs to detect SARS-CoV-2", "type": "journal-article", "update-policy": "https://doi.org/10.1371/journal.pone.corrections_policy", "volume": "20" }
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit